- Localization of HIV-1 Vpr to the nuclear envelope: Impact on Vpr functions and virus replication in macrophages

  1. Yamashita M, Emerman M: Retroviral infection of non-dividing cells: old and new perspectives.

    Virology 2006, 344:88-93.


  2. Crowe S, Zhu T, Muller WA: The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection.

    J Leukoc Biol 2003, 74:635-41.


  3. Yamashita M, Emerman M: The cell cycle independence of HIV infections is not determined by known karyophilic viral elements.

    PLoS Pathog 2005, 1:e18.


  4. Fassati A: HIV infection of non-dividing cells: a divisive problem.

    Retrovirology 2006, 3:74.


  5. Balliet JW, Kolson DL, Eiger G, Kim FM, McGann KA, Srinivasan A, Collman R: Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate.

    Virology 1994, 200:623-31.


  6. Connor RI, Chen BK, Choe S, Landau NR: Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.

    Virology 1995, 206:935-44.


  7. Eckstein DA, Sherman MP, Penn ML, Chin PS, De Noronha CM, Greene WC, Goldsmith MA: HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells.

    J Exp Med 2001, 194:1407-19.


  8. Heinzinger NK, Bukinsky MI, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, Gendelman HE, Ratner L, Stevenson M, Emerman M: The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.

    Proc Natl Acad Sci USA 1994, 91:7311-5.


  9. Zaitseva L, Myers R, Fassati A: tRNAs promote nuclear import of HIV-1 intracellular reverse transcription complexes.

    PLoS Biol 2006, 4:e332.


  10. Morellet N, Bouaziz S, Petitjean P, Roques BP: NMR structure of the HIV-1 regulatory protein VPR.

    J Mol Biol 2003, 327:215-27.


  11. Muller B, Tessmer U, Schubert U, Krausslich HG: Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells.

    J Virol 2000, 74:9727-31.


  12. Selig L, Pages JC, Tanchou V, Preveral S, Berlioz-Torrent C, Liu LX, Erdtmann L, Darlix J, Benarous R, Benichou S: Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses.

    J Virol 1999, 73:592-600.


  13. Cohen EA, Dehni G, Sodroski JG, Haseltine WA: Human immunodeficiency virus vpr product is a virion-associated regulatory protein.

    J Virol 1990, 64:3097-9.


  14. Paxton W, Connor RI, Landau NR: Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.

    J Virol 1993, 67:7229-37.


  15. Yu XF, Matsuda M, Essex M, Lee TH: Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein.

    J Virol 1990, 64:5688-93.


  16. Yuan X, Matsuda Z, Matsuda M, Essex M, Lee TH: Human immunodeficiency virus vpr gene encodes a virion-associated protein.

    AIDS Res Hum Retroviruses 1990, 6:1265-71.


  17. Le Rouzic E, Benichou S: The Vpr protein from HIV-1: distinct roles along the viral life cycle.

    Retrovirology 2005, 2:11.


  18. Goh WC, Rogel ME, Kinsey CM, Michael SF, Fultz PN, Nowak MA, Hahn BH, Emerman M: HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo.

    Nat Med 1998, 4:65-71.


  19. Chen R, Le Rouzic E, Kearney JA, Mansky LM, Benichou S: Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages.

    J Biol Chem 2004, 279(27):28419-28425.


  20. Di Marzio P, Choe S, Ebright M, Knoblauch R, Landau NR: Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.

    J Virol 1995, 69:7909-16.


  21. Kamata M, Aida Y: Two putative alpha-helical domains of human immunodeficiency virus type 1 Vpr mediate nuclear localization by at least two mechanisms.

    J Virol 2000, 74:7179-86.


  22. Waldhuber MG, Bateson M, Tan J, Greenway AL, McPhee DA: Studies with GFP-Vpr fusion proteins: induction of apoptosis but ablation of cell-cycle arrest despite nuclear membrane or nuclear localization.

    Virology 2003, 313:91-104.


  23. Depienne C, Roques P, Creminon C, Fritsch L, Casseron R, Dormont D, Dargemont C, Benichou S: Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses.

    Exp Cell Res 2000, 260:387-95.


  24. Popov S, Rexach M, Ratner L, Blobel G, Bukrinsky M: Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex.

    J Biol Chem 1998, 273:13347-52.


  25. Vodicka MA, Koepp DM, Silver PA, Emerman M: HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection.

    Genes Dev 1998, 12:175-85.


  26. Fouchier RA, Meyer BE, Simon JH, Fischer U, Albright AV, Gonzalez-Scarano F, Malim MH: Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex.

    J Virol 1998, 72:6004-13.


  27. Tran EJ, Wente SR: Dynamic nuclear pore complexes: life on the edge.

    Cell 2006, 125:1041-53.


  28. Le Rouzic E, Mousnier A, Rustum C, Stutz F, Hallberg E, Dargemont C, Benichou S: Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1.

    J Biol Chem 2002, 277:45091-8.


  29. Nitahara-Kasahara Y, Kamata M, Yamamoto T, Zhang X, Miyamoto Y, Muneta K, Iijima S, Yoneda Y, Tsunetsugu-Yokota Y, Aida Y: A novel nuclear import of Vpr promoted by importin {alpha} is crucial for HIV-1 replication in macrophages.

    J Virol 2007. JVI.01928-06


  30. Withers-Ward ES, Jowett JB, Stewart SA, Xie YM, Garfinkel A, Shibagaki Y, Chow SA, Shah N, Hanaoka F, Sawitz DG, Armstrong RW, Souza LM, Chen IS: Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair.

    J Virol 1997, 71:9732-42.


  31. Selig L, Benichou S, Rogel ME, Wu LI, Vodicka MA, Sire J, Benarous R, Emerman M: Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest.

    J Virol 1997, 71:4842-6.


  32. Mansky LM, Preveral S, Selig L, Benarous R, Benichou S: The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate.

    J Virol 2000, 74:7039-47.


  33. Schwede T, Kopp J, Guex N, Peitsch MC: SWISS-MODEL: An automated protein homology-modeling server.

    Nucleic Acids Res 2003, 31:3381-5.


  34. Guex N, Peitsch MC: SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.

    Electrophoresis 1997, 18:2714-23.


  35. Peitsch MC, Wells TN, Stampf DR, Sussman JL: The Swiss-3DImage collection and PDB-Browser on the World-Wide Web.

    Trends Biochem Sci 1995, 20:82-4.


  36. Mahalingam S, Ayyavoo V, Patel M, Kieber-Emmons T, Weiner DB: Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr.

    J Virol 1997, 71:6339-47.


  37. Yao XJ, Subbramanian RA, Rougeau N, Boisvert F, Bergeron D, Cohen EA: Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation.

    J Virol 1995, 69:7032-44.


  38. Thotala D, Schafer EA, Tungaturthi PK, Majumder B, Janket ML, Wagner M, Srinivasan A, Watkins S, Ayyavoo V: Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication.

    Virology 2004, 328:89-100.


  39. Yang XJ: Multisite protein modification and intramolecular signaling.

    Oncogene 2005, 24:1653-62.


  40. de Noronha CM, Sherman MP, Lin HW, Cavrois MV, Moir RD, Goldman RD, Greene WC: Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr.

    Science 2001, 294:1105-8.


  41. Somasundaran M, Sharkey M, Brichacek B, Luzuriaga K, Emerman M, Sullivan JL, Stevenson M: Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

    Proc Natl Acad Sci USA 2002, 99:9503-8.


  42. Le Rouzic E, Belaidouni N, Estrabaud E, Morel M, Rain JC, Transy C, Margottin-Goguet F: HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase.

    Cell Cycle 2007, 6:182-8.


  43. Hrecka K, Gierszewska M, Srivastava S, Kozaczkiewicz L, Swanson SK, Florens L, Washburn MP, Skowronski J: Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle.

    Proc Natl Acad Sci USA 2007, 104:11778-83.


  44. Belzile JP, Duisit G, Rougeau N, Mercier J, Finzi A, Cohen EA: HIV-1 Vpr-Mediated G2 Arrest Involves the DDB1-CUL4A(VPRBP) E3 Ubiquitin Ligase.

    PLoS Pathog 2007, 3:e85.


  45. Tan L, Ehrlich E, Yu XF: DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest.

    J Virol 2007, 81(19):10822-10830.


  46. DeHart JL, Zimmerman ES, Ardon O, Monteiro-Filho CM, Arganaraz ER, Planelles V: HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system.

    Virol J 2007, 4:57.


  47. Andersen JL, Zimmerman ES, DeHart JL, Murala S, Ardon O, Blackett J, Chen J, Planelles V: ATR and GADD45alpha mediate HIV-1 Vpr-induced apoptosis.

    Cell Death Differ 2005, 12:326-34.


  48. Muthumani K, Hwang DS, Desai BM, Zhang D, Dayes N, Green DR, Weiner DB: HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells.

    J Biol Chem 2002, 277:37820-31.


  49. Stewart SA, Poon B, Song JY, Chen IS: Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation.

    J Virol 2000, 74:3105-11.


  50. Yuan H, Xie YM, Chen IS: Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr- and gamma irradiation-induced apoptosis.

    J Virol 2003, 77:2063-70.


  51. Yuan H, Kamata M, Xie YM, Chen IS: Increased levels of Wee-1 kinase in G(2) are necessary for Vpr- and gamma irradiation-induced G(2) arrest.

    J Virol 2004, 78:8183-90.


  52. Chen M, Elder RT, Yu M, O'Gorman MG, Selig L, Benarous R, Yamamoto A, Zhao Y: Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast.

    J Virol 1999, 73:3236-45.


  53. Nishizawa M, Kamata M, Mojin T, Nakai Y, Aida Y: Induction of apoptosis by the Vpr protein of human immunodeficiency virus type 1 occurs independently of G(2) arrest of the cell cycle.

    Virology 2000, 276:16-26.


  54. Lum JJ, Cohen OJ, Nie Z, Weaver JG, Gomez TS, Yao XJ, Lynch D, Pilon AA, Hawley N, Kim JE, Chen Z, Montpetit M, Sanchez-Dardon J, Cohen EA, Badley AD: Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis.

    J Clin Invest 2003, 111:1547-54.


  55. Andersen JL, Dehart JL, Zimmerman ES, Ardon O, Kim B, Jacquot G, Benichou S, Planelles V: HIV-1 Vpr-Induced Apoptosis Is Cell Cycle Dependent and Requires Bax but Not ANT.

    PLoS Pathog 2006, 2:e127.


  56. Freed EO, Englund G, Martin MA: Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.

    J Virol 1995, 69:3949-54.


  57. Subbramanian RA, Yao XJ, Dilhuydy H, Rougeau N, Bergeron D, Robitaille Y, Cohen EA: Human immunodeficiency virus type 1 Vpr localization: nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity.

    J Mol Biol 1998, 278:13-30.


  58. Cadwell RC, Joyce GF: Randomization of genes by PCR mutagenesis.

    PCR Methods Appl 1992, 2:28-33.


  59. Py B, Slomianny C, Auberger P, Petit PX, Benichou S: Siva-1 and an alternative splice form lacking the death domain, Siva-2, similarly induce apoptosis in T lymphocytes via a caspase-dependent mitochondrial pathway.

    J Immunol 2004, 172:4008-17.


  60. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D: Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.

    Nat Biotechnol 1997, 15:871-5.


  61. Adam SA, Marr RS, Gerace L: Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factors.

    J Cell Biol 1990, 111:807-16.


  62. Mansky LM, Preveral S, Le Rouzic E, Bernard LC, Selig L, Depienne C, Benarous R, Benichou S: Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr.

    Virology 2001, 282:176-85.


  63. Perez-Bercoff D, David A, Sudry H, Barre-Sinoussi F, Pancino G: Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages.

    J Virol 2003, 77:4081-94.


rating: 0.00 from 0 votes | updated on: 15 May 2008 | views: 14842 |

Rate article:

excellent! bad…